Schonfeld Strategic Advisors LLC Shattuck Labs, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 30,700 shares of STTK stock, worth $23,332. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,700
Previous 37,400
17.91%
Holding current value
$23,332
Previous $45,000
35.56%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding STTK
# of Institutions
62Shares Held
29.8MCall Options Held
0Put Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$5.05 Million2.25% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$4.21 Million0.55% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$3.55 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$1.88 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$1.63 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $32.2M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...